Dementia with Lewy bodies: an update and outlook

作者: Tiago Fleming Outeiro , David J. Koss , Daniel Erskine , Lauren Walker , Marzena Kurzawa-Akanbi

DOI: 10.1186/S13024-019-0306-8

关键词:

摘要: Dementia with Lewy bodies (DLB) is an age-associated neurodegenerative disorder producing progressive cognitive decline that interferes normal life and daily activities. Neuropathologically, DLB characterised by the accumulation of aggregated α-synuclein protein in neurites, similar to Parkinson’s disease (PD). Extrapyramidal motor features characteristic PD, are common patients, but not essential for clinical diagnosis DLB. Since many PD patients develop dementia as progresses, there has been controversy about separation from (PDD) consensus reports have put forward guidelines assist clinicians identification management both syndromes. Here, we present basic concepts definitions, based on our current understanding, should guide community address open questions will, hopefully, lead us towards improved novel therapeutic strategies other synucleinopathies.

参考文章(213)
M. S. Pollanen, L. Weyer, C. Bergeron, C. Petrunka, Altered neurofilament expression does not contribute to Lewy body formation. American Journal of Pathology. ,vol. 148, pp. 267- 272 ,(1996)
Yuko Saito, Akiko Kawashima, Nyoka N. Ruberu, Hideo Fujiwara, Shunichi Koyama, Motoji Sawabe, Tomio Arai, Hiroshi Nagura, Hiroshi Yamanouchi, Masato Hasegawa, Takeshi Iwatsubo, Shigeo Murayama, Accumulation of Phosphorylated α-Synuclein in Aging Human Brain Journal of Neuropathology and Experimental Neurology. ,vol. 62, pp. 644- 654 ,(2003) , 10.1093/JNEN/62.6.644
Hideo Fujiwara, Masato Hasegawa, Naoshi Dohmae, Akiko Kawashima, Eliezer Masliah, Matthew S. Goldberg, Jie Shen, Koji Takio, Takeshi Iwatsubo, |[alpha]|-Synuclein is phosphorylated in synucleinopathy lesions Nature Cell Biology. ,vol. 4, pp. 160- 164 ,(2002) , 10.1038/NCB748
Laura Parkkinen, Sean S. O'Sullivan, Catherine Collins, Aviva Petrie, Janice L. Holton, Tamas Revesz, Andrew J. Lees, Disentangling the Relationship between Lewy Bodies and Nigral Neuronal Loss in Parkinson's Disease Journal of Parkinson's disease. ,vol. 1, pp. 277- 286 ,(2011) , 10.3233/JPD-2011-11046
Maria Grazia Spillantini, Marie Luise Schmidt, Virginia M.-Y. Lee, John Q. Trojanowski, Ross Jakes, Michel Goedert, α-Synuclein in Lewy bodies Nature. ,vol. 388, pp. 839- 840 ,(1997) , 10.1038/42166
Antony J. Harding, Glenda M. Halliday, Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathologica. ,vol. 102, pp. 355- 363 ,(2001) , 10.1007/S004010100390
Walter A. Kukull, Oscar Lopez, Douglas Galasko, Eliezer Masliah, Jeffrey Kaye, Randall Woltjer, Christopher Clark, John Q. Trojanowski, Thomas J. Montine, James B. Leverenz, Ronald Hamilton, Debby W. Tsuang, Aimee Schantz, Darcy Vavrek, Eric B. Larson, RESEARCH ARTICLE: Empiric Refinement of the Pathologic Assessment of Lewy-Related Pathology in the Dementia Patient Brain Pathology. ,vol. 18, pp. 220- 224 ,(2008) , 10.1111/J.1750-3639.2007.00117.X
D. Weisman, M. Cho, C. Taylor, A. Adame, L. J. Thal, L. A. Hansen, In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution Neurology. ,vol. 69, pp. 356- 359 ,(2007) , 10.1212/01.WNL.0000266626.64913.0F
James E. Galvin, IMPROVING THE CLINICAL DETECTION OF LEWY BODY DEMENTIA WITH THE LEWY BODY COMPOSITE RISK SCORE. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. ,vol. 1, pp. 316- 324 ,(2015) , 10.1016/J.DADM.2015.05.004